
ADARx Pharmaceuticals, Inc. owns 1 brand in our database. Browse the complete portfolio of ADARx Pharmaceuticals, Inc. subsidiaries and brands across various industries.
Company Type
public
Headquarters
San Diego, California, United States
Brand Portfolio
1 brands
Stock
Nasdaq: ADRX
What does ADARx do?
ADARx develops siRNA therapeutics that silence disease-driving genes. Its pipeline targets cardiovascular, metabolic, complement, and neurological conditions using delivery technology that reaches tissues beyond the liver.
Is ADARx publicly traded?
Yes. ADARx listed on Nasdaq under ticker ADRX on September 24, 2026, raising approximately $446 million.
Who founded ADARx?
Zhen Li co-founded the company in December 2019 and serves as president and CEO. She previously led siRNA research at Arrowhead Pharmaceuticals and Merck.
Where is ADARx headquartered?
ADARx is headquartered at 5871 Oberlin Drive in San Diego, California.
Who owns ADARx?
After the IPO, ADARx is owned by public shareholders, founders, employees, and venture investors. AbbVie holds approximately 4.9% through an IPO investment capped at $100 million.
When did ADARx IPO?
ADARx priced its IPO on September 24, 2026, selling 26.25 million shares at $17 each for gross proceeds of approximately $446.3 million.
No competing brands found in the same categories. This could be because ADARx Pharmaceuticals, Inc.operates in unique market segments or we're still building our competitor database.
ADARx Pharmaceuticals, Inc. maintains a diverse portfolio of 1 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by ADARx Pharmaceuticals, Inc.provides valuable insights into market dynamics, product relationships, and corporate strategy.